Samsara BioCapital »

Parabilis Medicines shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2026-06-30 $15M 556k 27.37

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Alumis (ALMS)
Mineralys Therapeutics (MLYS)
Septerna (SEPN)
Alamar Biosciences Common Stock
Neurogene (NGNE)
Kalaris Therapeutics (KLRS)
Spyglass Pharma Com Shs (SGP)
Sutro Biopharma Com Shs (STRO)
Inventiva Sa Ads (IVA)
Jade Biosciences Com New (JBIO)
Parabilis Medicines
Vtv Therapeutics Cl A New (VTVT)
Aquestive Therapeutics (AQST)
Nkarta (NKTX)

View all positions for Samsara BioCapital

Top funds holding Parabilis Medicines

RA Capital Management
Arch Venture Corp
venBio Partners
Nextech Invest
Regeneron Pharmaceuticals
Jupiter Topco
Soleus Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
Jpmorgan Chase & Co
Alliancebernstein
VR Adviser
Samsara BioCapital
Baker Bros. Advisors
Marshall Wace

View all funds holding Parabilis Medicines